{"id":47392,"date":"2022-08-17T16:02:09","date_gmt":"2022-08-17T14:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/"},"modified":"2022-08-17T16:02:09","modified_gmt":"2022-08-17T14:02:09","slug":"14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/","title":{"rendered":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 &#8211; Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5642358\/wearable-injectors-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vx6xx9&amp;utm_campaign=1739268+-+%2414.4+Billion+Worldwide+Wearable+Injectors+Industry+to+2027+-+Featuring+Dexcom%2C+Enable+Injections%2C+Gerresheimer+and+Insulet+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.7% during 2021-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nBecton Dickinson Company\n<\/li>\n<li>\nCeQur SA\n<\/li>\n<li>\nDebiotech SA\n<\/li>\n<li>\nDexcom Inc.\n<\/li>\n<li>\nEnable Injections Inc.\n<\/li>\n<li>\nGerresheimer AG\n<\/li>\n<li>\nInsulet Corporation\n<\/li>\n<li>\nTandem Diabetes Care Inc.\n<\/li>\n<li>\nWest Pharmaceutical Services Inc.\n<\/li>\n<li>\nYpsomed AG.\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nWearable injectors, or patch pumps, are compact drug delivery devices used for single-step administration of medicines for longer durations. They are temporarily pasted on the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body.\n<\/p>\n<p>\nThey are commonly available in on-body and off-body injector variants and the device consists of a reservoir to store medicine, a cannula for substance delivery to tissues and a drive system to deliver the appropriate drug volume. In comparison to the traditionally used vials and syringes, wearable injectors are disposable, user-friendly, cause minimal discomfort and pain. As a result, they are widely used in the treatment of cancer, diabetes, rheumatoid arthritis and cardiovascular diseases.\n<\/p>\n<p>\nThe increasing prevalence of chronic medical ailments, such as oncological, neurological and autoimmune disorders, is of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and the increasing demand for minimally invasive (MI) treatment alternatives among the patients are providing a thrust to the growth of the market.\n<\/p>\n<p>\nThere is also a growing preference for at-home and self-administrable injectors to effectively manage the ailments with minimal risks of inaccurate dosage and needle stick injuries. Additionally, various product innovations, such as integration of passive warning systems, wireless connectivity and Bluetooth technologies with the injectors, are acting as other growth-inducing factors.\n<\/p>\n<p>\nThese technologies facilitate convenient monitoring of the patient through a smartphone application and provide timely reminders for dosages. Other factors, including extensive research and development activities, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipating to the drive the market toward growth.\n<\/p>\n<p>\n<strong>Key Questions Answered in This Report:<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global wearable injectors market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global wearable injectors market?\n<\/li>\n<li>\nWhat are the key regional markets?\n<\/li>\n<li>\nWhat is the breakup of the market based on the type?\n<\/li>\n<li>\nWhat is the breakup of the market based on the technology?\n<\/li>\n<li>\nWhat is the breakup of the market based on the application?\n<\/li>\n<li>\nWhat is the breakup of the market based on the end use?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the industry?\n<\/li>\n<li>\nWhat is the structure of the global wearable injectors market and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the industry?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Preface<\/strong>\n<\/p>\n<p>\n<strong>2 Scope and Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Introduction<\/strong>\n<\/p>\n<p>\n4.1 Overview\n<\/p>\n<p>\n4.2 Key Industry Trends\n<\/p>\n<p>\n<strong>5 Global Wearable Injectors Market<\/strong>\n<\/p>\n<p>\n5.1 Market Overview\n<\/p>\n<p>\n5.2 Market Performance\n<\/p>\n<p>\n5.3 Impact of COVID-19\n<\/p>\n<p>\n5.4 Market Forecast\n<\/p>\n<p>\n<strong>6 Market Breakup by Type<\/strong>\n<\/p>\n<p>\n<strong>7 Market Breakup by Technology<\/strong>\n<\/p>\n<p>\n<strong>8 Market Breakup by Application<\/strong>\n<\/p>\n<p>\n<strong>9 Market Breakup by End Use<\/strong>\n<\/p>\n<p>\n<strong>10 Market Breakup by Region<\/strong>\n<\/p>\n<p>\n<strong>11 SWOT Analysis<\/strong>\n<\/p>\n<p>\n<strong>12 Value Chain Analysis<\/strong>\n<\/p>\n<p>\n<strong>13 Porters Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>14 Price Analysis<\/strong>\n<\/p>\n<p>\n<strong>15 Competitive Landscape<\/strong>\n<\/p>\n<p>\n15.1 Market Structure\n<\/p>\n<p>\n15.2 Key Players\n<\/p>\n<p>\n15.3 Profiles of Key Players\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5642358\/wearable-injectors-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vx6xx9&amp;utm_campaign=1739268+-+%2414.4+Billion+Worldwide+Wearable+Injectors+Industry+to+2027+-+Featuring+Dexcom%2C+Enable+Injections%2C+Gerresheimer+and+Insulet+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/jcgfnm<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#x3a;&#112;&#x72;&#x65;&#115;&#x73;&#x40;r&#x65;&#x73;e&#x61;&#114;c&#x68;&#97;n&#x64;&#109;a&#x72;&#107;e&#x74;&#115;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#x65;&#x73;&#115;&#x40;&#x72;&#101;&#x73;&#x65;&#97;&#x72;&#x63;h&#x61;&#x6e;d&#x6d;&#97;r&#x6b;&#101;t&#x73;&#46;c&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.7% &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47392","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.7% ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-17T14:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 &#8211; Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-17T14:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/\"},\"wordCount\":676,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005489\\\/en\\\/1546892\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/\",\"name\":\"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005489\\\/en\\\/1546892\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-17T14:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005489\\\/en\\\/1546892\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005489\\\/en\\\/1546892\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 &#8211; Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.7% ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-17T14:02:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 &#8211; Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-08-17T14:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/"},"wordCount":676,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/","name":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 - Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg","datePublished":"2022-08-17T14:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220817005489\/en\/1546892\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/14-4-billion-worldwide-wearable-injectors-industry-to-2027-featuring-dexcom-enable-injections-gerresheimer-and-insulet-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"$14.4 Billion Worldwide Wearable Injectors Industry to 2027 &#8211; Featuring Dexcom, Enable Injections, Gerresheimer and Insulet Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47392"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47392\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}